The therapeutic potential of sialylated fragment crystallizable (Fc) domains of human IgG

Pleass, Richard ORCID: https://orcid.org/0000-0001-7438-8296 (2021) 'The therapeutic potential of sialylated fragment crystallizable (Fc) domains of human IgG'. mAbs, Vol 13, Issue 1.

	Text Review Revision for mAbs copy31.docx - Accepted Version Restricted to Repository staff only Download (6MB)
Preview	Text The therapeutic potential of sialylated Fc domains of human IgG.pdf - Published Version Available under License Creative Commons Attribution. Download (2MB) | Preview

Abstract

Pathogens frequently use multivalent binding to sialic acid to infect cells or to modulate immunity through interactions with human sialic acid-binding immunoglobulin-type lectins (Siglecs). Molecules that interfere with these interactions could be of interest as diagnostics, anti-infectives or as immune modulators. This review describes the development of molecular scaffolds based on the crystallizable fragment (Fc) region of immunoglobulin (Ig) G that deliver high-avidity binding to innate immune receptors, including sialic acid-dependent receptors. The ways in which the sialylated Fc may be engineered as immune modulators that mimic the anti-inflammatory properties of intravenous polyclonal Ig or as blockers of sialic-acid-dependent infectivity by viruses are also discussed.

Item Type:	Article
Subjects:	QU Biochemistry > QU 4 General works QU Biochemistry > Proteins. Amino Acids. Peptides > QU 55 Proteins QW Microbiology and Immunology > Antigens and Antibodies. Toxins and Antitoxins > QW 575 Antibodies
Faculty: Department:	Biological Sciences > Department of Tropical Disease Biology
Digital Object Identifer (DOI):	https://doi.org/10.1080/19420862.2021.1953220
Depositing User:	Cathy Waldron
Date Deposited:	12 Jul 2021 11:41
Last Modified:	27 Jul 2021 13:58
URI:	https://archive.lstmed.ac.uk/id/eprint/18283

Statistics

View details

Actions (login required)

Edit Item